4492 T3D4438 Coproporphyrinogen III Coproporphyrinogen III oxidase is deficient in hereditary coproporphyria. These persons usually have enhanced excretion even in a subclinical state of the disease. (A3500). 2624-63-7 321 C36H44N4O8 White powder. No indication of carcinogenicity to humans (not listed by IARC). This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation. 2014-08-29T06:51:16Z 2026-04-05T11:56:31Z Coproporphyrinogen III C03263 15439 COPROPORPHYRINOGEN_III DB04461 CP3 true CC1=C2CC3=C(C)C(CCC(O)=O)=C(CC4=C(CCC(O)=O)C(C)=C(CC5=C(CCC(O)=O)C(C)=C(CC(N2)=C1CCC(O)=O)N5)N4)N3 C36H44N4O8 InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48) NIUVHXTXUXOFEB-UHFFFAOYSA-N 660.7566 660.315914404 Endogenous Solid HMDB01261 CHEMBL1231891 315 <p>Ichiro Kojima, Kenji Maruhashi, Yasuo Fujiwara, &#8220;Process for producing coproporphyrin <span class="caps">III</span>.&#8221; U.S. Patent US4334021, issued September, 1978.</p> CHEM003398 DTXSID40180875 3-[9,14,20-tris(2-carboxyethyl)-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid